Insulet Corporation (PODD): Price and Financial Metrics


Insulet Corporation (PODD): $230.32

-1.36 (-0.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PODD POWR Grades


  • Growth is the dimension where PODD ranks best; there it ranks ahead of 99.22% of US stocks.
  • PODD's strongest trending metric is Stability; it's been moving down over the last 179 days.
  • PODD's current lowest rank is in the Momentum metric (where it is better than 5.5% of US stocks).

PODD Stock Summary

  • With a one year PEG ratio of 2,187.48, Insulet Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 98.42% of US stocks.
  • PODD's current price/earnings ratio is 1,073.78, which is higher than 99.19% of US stocks with positive earnings.
  • With a price/sales ratio of 16.42, Insulet Corp has a higher such ratio than 91.34% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Insulet Corp, a group of peers worth examining would be PCTI, SCL, INVE, RMD, and APPS.
  • PODD's SEC filings can be seen here. And to visit Insulet Corp's official web site, go to www.insulet.com.

PODD Valuation Summary

  • PODD's price/earnings ratio is -672.5; this is 1942.47% lower than that of the median Healthcare stock.
  • Over the past 174 months, PODD's price/sales ratio has gone down 86.7.
  • PODD's EV/EBIT ratio has moved up 1031.5 over the prior 174 months.

Below are key valuation metrics over time for PODD.

Stock Date P/S P/B P/E EV/EBIT
PODD 2021-08-31 20.6 44.7 -672.5 1020.1
PODD 2021-08-30 20.5 44.4 -668.8 1014.6
PODD 2021-08-27 20.4 44.3 -666.4 1011.0
PODD 2021-08-26 20.3 44.1 -664.2 1007.8
PODD 2021-08-25 20.7 45.0 -676.9 1026.7
PODD 2021-08-24 20.8 45.0 -677.5 1027.6

PODD Growth Metrics

    Its 3 year revenue growth rate is now at 74.25%.
  • Its 5 year net income to common stockholders growth rate is now at 106.91%.
  • Its year over year revenue growth rate is now at 23.44%.
PODD's revenue has moved up $499,000,000 over the prior 34 months.

The table below shows PODD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 1,098.8 -68.1 16.8
2021-09-30 1,037.2 -43.6 -29.5
2021-06-30 995.6 44.4 -30.5
2021-03-31 958.7 52.5 8.9
2020-12-31 904.4 84 6.8
2020-09-30 867.694 131.933 28.868

PODD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PODD has a Quality Grade of C, ranking ahead of 61.86% of graded US stocks.
  • PODD's asset turnover comes in at 0.542 -- ranking 84th of 186 Medical Equipment stocks.
  • UFPT, NEPH, and NSPR are the stocks whose asset turnover ratios are most correlated with PODD.

The table below shows PODD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.542 0.666 0.011
2021-03-31 0.544 0.650 0.036
2020-12-31 0.573 0.644 0.034
2020-09-30 0.621 0.640 0.049
2020-06-30 0.642 0.638 0.040
2020-03-31 0.691 0.644 0.029

PODD Price Target

For more insight on analysts targets of PODD, see our PODD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $290.41 Average Broker Recommendation 1.6 (Moderate Buy)

PODD Stock Price Chart Interactive Chart >

Price chart for PODD

PODD Price/Volume Stats

Current price $230.32 52-week high $324.81
Prev. close $231.68 52-week low $181.00
Day low $228.00 Volume 337,900
Day high $235.89 Avg. volume 597,278
50-day MA $216.11 Dividend yield N/A
200-day MA $255.71 Market Cap 15.97B

Insulet Corporation (PODD) Company Bio


Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company was founded in 2000 and is based in Billerica, Massachusetts.


PODD Latest News Stream


Event/Time News Detail
Loading, please wait...

PODD Latest Social Stream


Loading social stream, please wait...

View Full PODD Social Stream

Latest PODD News From Around the Web

Below are the latest news stories about Insulet Corp that investors may wish to consider to help them evaluate PODD as an investment opportunity.

10 Companies That Topped Profit Expectations

In this article, we will take a look at the 10 companies that topped profit expectations. You can skip our detailed analysis of these companies and go directly to the 5 Companies That Topped Profit Expectations. Notable stocks from the consumer cyclical sector, including Booking Holdings Inc. (NASDAQ:BKNG), eBay Inc. (NASDAQ:EBAY) and Bath & Body […]

Yahoo | February 25, 2022

Insulet Corporation (PODD) CEO Shacey Petrovic On Q4 2021 Results - Earnings Call Transcript

Insulet Corporation (PODD) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Deborah Gordon - VP, IR Shacey Petrovic - President & CEO Wayde McMillan - EVP & CFO Bret Christensen - EVP & Chief Commercial Officer Conference Call Participants Jayson Bedford - Raymond James Robbie...

SA Transcripts on Seeking Alpha | February 24, 2022

Insulet Posts Street-Beating Q4 Earnings, Omnipod Revenues Up ~20%

Insulet Corp''s (NASDAQ: PODD ) Q4 FY21 revenue increased 25% (25.7% in constant currency) to $307.7 million , exceeding the consensus of $301.06 million. The company brought in $275.8 million in revenues for its Omnipod insulin delivery platform for the quarter, representing a 19.3% increase. Insulet posted Q4 EPS of $0.42, a shift from EPS loss of $(0.26) a year … Full story available on Benzinga.com

Benzinga | February 24, 2022

Insulet (PODD) Q4 Earnings Surpass Estimates, Margins Up

Insulet's (PODD) fourth-quarter 2021 revenues improved year over year on a strong performance of Omnipod, both in U.S. and international markets.

Yahoo | February 24, 2022

Insulet: Heroic Assumptions Still Required

Image: Convenient insulin pump diabetes technology Investment Thesis Back in October 2021, with the Insulet (PODD) share price at $308.90, I published article, "Insulet: Heroic Assumptions Required". The share price has since fallen by 24.19% since date of article publication, compared to a fall of 4.90% for the S&P 500...

Robert Honeywill on Seeking Alpha | February 23, 2022

Read More 'PODD' Stories Here

PODD Price Returns

1-mo 8.63%
3-mo -13.90%
6-mo -7.90%
1-year -19.68%
3-year 92.17%
5-year 346.96%
YTD -13.44%
2021 4.08%
2020 49.32%
2019 115.83%
2018 14.96%
2017 83.12%

Continue Researching PODD

Here are a few links from around the web to help you further your research on Insulet Corp's stock as an investment opportunity:

Insulet Corp (PODD) Stock Price | Nasdaq
Insulet Corp (PODD) Stock Quote, History and News - Yahoo Finance
Insulet Corp (PODD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5508 seconds.